Author: Avalon Health Economics LLC

Economic Evaluation and Market Access for Medical Devices in the U.S.: Implications of a U.S. Health Technology Assessment Agency
June 15, 2021 - 3:14 pm, by
The Biden Administration has indicated an intent to explore the creation of a government-operated health technology assessment (HTA) agency to engage in some form of review of biopharmaceuticals and other medical technologies.
MO551 A Cost-Offset Analysis of the Roxadustat Dialysis-Dependent Global Phase 3 Program: A Canadian Healthcare Perspective
May 30, 2021 - 11:27 am, by
Chronic kidney disease (CKD) is a costly public health issue, which affects 13.4% of the population globally.
Lost in Transmission: Analytic Applications of Public Health Data to Inform Evaluations of the Efficacy, Effectiveness, and Value of Interventions for COVID-19
May 29, 2021 - 11:33 am, by
Together with our colleagues at Broadstreet Health Economics and Outcomes Research, Avalon’s John Schneider took part in an ISPOR workshop entitled “Lost in Transmission: Analytic Applications of Public Health Data to Inform Evaluations of the Efficacy, Effectiveness, and Value of Interventions for COVID-19.”
Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19- A Comparison of Two Methods
May 29, 2021 - 11:28 am, by
John Schneider and Amanda Howarth collaborated with Broadstreet Health Economics and Outcomes Research on a poster entitled “Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19- A Comparison of Two Methods".
Mendelian Randomization: Estimation of Inpatient Hospital Costs Attributable to Obesity
May 15, 2021 - 11:33 am, by
The Avalon team employed Mendelian randomization to help Novartis understand the proportion of obesity costs that might be explained by genetic causes.
One Year into the Pandemic: Where are we Now?
April 28, 2021 - 10:28 am, by
In this blog entry, we briefly review where we are at now, one year after all of this started.
Online Simulation Model to Estimate the Total Costs of Tobacco Product Waste in Large U.S. Cities
July 1, 2020 - 4:42 pm, by
Tobacco product waste (TPW) is one of the most ubiquitous forms of litter, accumulating in large amounts on streets, highways, sidewalks, beaches, parks, and other public places, and flowing into storm water drains, waste treatment plants, and solid waste collection facilities.
Telehealth and Telemedicine in the Post-Pandemic Era
June 18, 2020 - 12:42 pm, by
In many ways the arrival of the COVID-19 pandemic globally was met with sub-optimal levels of preparedness on the part of health care providers and provider systems, such as integrated delivery networks (IDNs).
Moving Beyond ‘Lives-Saved’ From COVID-19
May 15, 2020 - 4:51 pm, by
This blog covers the presentation given as part of the ISPOR pre-conference plenary session on HEOR in the era of COVID-19 which was held on 14 May 2020.
Economic Cycles and Product Development in Life Sciences
May 11, 2020 - 4:33 pm, by
Economic Cycles and Product Development in Life Sciences May 11, 2020 By John Schneider, PhD and Mirela Sima, MD, MBA The humanistic and economic consequences of the 2020 COVID-19 pandemic will not be completely understood for years. The humanistic toll has been well documented; as of early May 2020, the global death toll attributable to...
Avalon Health Economics LLC